Skip to content
Disclosery

Calydon Capital: CVS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Calydon Capital on CVS, newest first. How the timeline and the estimate are built.

Calydon Capital held 94,666 CVS shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 94,666 shares
    Change vs previous 13F -1,586 shares

    1.43% of the 13F portfolio, value $9,793,219.

    13F-HR 0001104659-26-096633 filed by Calydon Capital
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 96,252 shares
    Change vs previous 13F +471 shares

    1.13% of the 13F portfolio, value $6,912,818.

    13F-HR 0001104659-26-061985 filed by Calydon Capital
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 95,781 shares
    Change vs previous 13F -635 shares

    1.28% of the 13F portfolio, value $7,601,167.

    13F-HR 0001104659-26-016164 filed by Calydon Capital
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 96,416 shares
    Change vs previous 13F +44,557 shares

    1.16% of the 13F portfolio, value $7,268,778.

    13F-HR 0001104659-25-112136 filed by Calydon Capital
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 51,859 shares
    Change vs previous 13F not available

    0.35% of the 13F portfolio, value $3,577,253.

    13F-HR 0001104659-25-078447 filed by Calydon Capital
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).